Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;99(4):384-8.
doi: 10.1016/j.ymgme.2009.12.010. Epub 2009 Dec 21.

The redox status of cystinotic fibroblasts

Affiliations

The redox status of cystinotic fibroblasts

Victor Vitvitsky et al. Mol Genet Metab. 2010 Apr.

Abstract

A key unresolved question in the pathogenesis of phenotype development in nephropathic cystinosis is whether intralysosomal cystine, the hallmark of this lethal inborn error of metabolism, alters cytoplasmic redox potential. Variable findings on this issue have been reported. This study of fetal and non-fetal skin and lung-derived cystinotic fibroblasts compared to origin and age-matched normal control fibroblasts reveals that cystinotic cells do not exhibit redox perturbations. We find that the steady-state redox status as assessed by the [GSH]/[GSSG] ratio, an indicator of the intracellular redox poise, is unchanged in cystinotic cells. Furthermore, the dependence of the intracellular GSH and cysteine pool sizes and the [GSH]/[GSSG] ratio are similarly dependent on the two major sources of cysteine, i.e. the transsulfuration pathway and the plasma membrane cystine transporter, xc(-), in both cystinotic and control cells, and the presence of lysosomal cystine has no measurable effect on the redox status of these cells. Hence, mechanisms other than cytosolic redox perturbations are involved in the etiology of nephropathic cystinosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Outline of the GSH biosynthetic pathway and the sites of action of the inhibitors used in this study. Propargylglycine (PPG) inhibits cystathionine γ-lyaseformula imageCGL) preventing cysteine synthesis from methionine (Met) via the transsulfuration pathway. Sulfasalazine (SAS) inhibits the transmembrane cystine transporter xc-. Both inhibitors can decrease the intracellular cysteine concentration and thus cause a decrease in intracellular GSH concentration. CBS denotes cystathionine formula image-synthase, the first enzyme or transsulfuration pathway.
Fig. 2
Fig. 2
The influence of propargylglycine and sulfasalazine on thiols in normal and cystinotic non-fetal human skin fibroblasts. Data are the average of two measurements.
Fig. 3
Fig. 3
The influence of propargylglycine and sulfasalazine on thiol metabolites in normal and cystinotic fetal human lung fibroblasts. Data are the average of two measurements.

Similar articles

Cited by

References

    1. Gahl WA, Thoene J, Schneider J. Cystinosis: A disorder of lysosomal membrane transport. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th edition McGraw Hill; 2001. pp. 5085–5108.
    1. Town M, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nature Genet. 1998;18:319–324. - PubMed
    1. Thoene J, Oshima R, Crawhall J, Olson D, Schneider J. Cystinosis: Intracellular Cystine Depletion by Aminothiols in Vitro and in Vivo. J. Clin. Invest. 1976;58:180–189. - PMC - PubMed
    1. Oshima R, Rhead W, Thoene J, Schneider J. Cystine Metabolism in Human Fibroblasts. J. Biol. Chem. 1976;251:4287–4293. - PubMed
    1. Patrick A. Deficiences of -SH-dependent enzymes in cystinosis. J.Clin.Path. 1965;28:427–443. - PubMed

Publication types

LinkOut - more resources